Goldman Sachs
GENE

Goldman Sachs’s Genetic Technologies Ltd. GENE Stock Holding History

Goldman Sachs’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,272
Closed -$48K – 6585
2021
Q2 		$48K Sell
2,272
-2,048
-47% -$41.3K ﹤0.01% 6072
2021
Q1 		$90K Buy
+4,320
New +$98.8K ﹤0.01% 5864

Other funds holding GENE

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Goldman Sachs's GENE Position: Q3 2021 in Review

Goldman Sachs sold out of Genetic Technologies Ltd. (GENE) in Q3 2021, closing a stake of 2,272 shares — an estimated $48K sold.

Goldman Sachs first reported a position in GENE in Q1 2021 and held it in 2 quarters. The position peaked at $90K in Q1 2021. 12 funds tracked by Wall St. Rank hold GENE as of Q3 2021.

  • Goldman Sachs reported no remaining Genetic Technologies Ltd. position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 2,272 Genetic Technologies Ltd. shares in Q3 2021, an estimated $48K.
  • Goldman Sachs first reported a position in Genetic Technologies Ltd. in Q1 2021 and held it in 2 quarters.
  • Goldman Sachs's Genetic Technologies Ltd. position peaked at $90K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.